Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival.
Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers.
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression.
MET and phosphorylated MET as potential biomarkers in lung cancer.
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer. J Carcinog. 2008; 7:9.
View in:
PubMed
authors with profiles
Ravi Salgia